期刊文献+

辛伐他汀治疗不稳定心绞痛的作用探讨 被引量:3

Clinical study of Simvastatin for the treatment of unstable angina pectoris
下载PDF
导出
摘要 目的:观察辛伐他汀在治疗不稳定心绞痛的治疗作用。方法:将60例不稳定心绞痛患者随机分为治疗组(30例)和对照组(30例),在常规治疗基础上治疗组每晚睡前加服辛伐他汀40mg,8周后观察临床疗效及血脂变化。结果:治疗组治疗后血清胆固醇(TC)及低密度脂蛋白胆固醇(LDL-C)水平明显下降(P﹤0.05),甘油三酯(TG)水平轻度下降,高密度脂蛋白胆固醇(HDL-C)水平轻度升高,治疗组临床症状明显改善,与对照组比较具有显著性差异(P﹤0.05)。结论:辛伐他汀具有调脂作用,对不稳定心绞痛治疗有显著疗效,可改善预后,在临床上具有较大的实用价值。 Objective:To evaluate effects of simvastatin for the treatment of unstable angina pectoris(UAP).Methods Sixty patients with UAP were randomly divided into control group(with conventional therapy,n=30) and simvastatin group(with conventional therapy and simvastatin 40mg before retiring,n=30),the therapeutic effects and serum lipids variation were assessed after 8 weeks.Results In simvastatin group,the levels of serum total cholesterol(TC) and lower density lipid cholesterol(LDL-C) decreased significantly,triglyc-erides(TG) decreased lightly,higher density lipid cholesterol(HDL-C) increased lightly,clinical symptom improved significantly com-pared with the control group(P﹤0.05),but there was no significant change in control group(P﹤0.05).Conclusion Simvastatin can regulate the serum lipids,the therapeutic effects are significant and improve prognosis in the treatment of UAP.
出处 《内蒙古中医药》 2008年第10X期3-4,共2页 Inner Mongolia Journal of Traditional Chinese Medicine
关键词 辛伐他汀 治疗 不稳定心绞痛 Simvastatin Treatment unstable angina pectoris
  • 相关文献

参考文献6

二级参考文献47

  • 1郭霞,宁亚兰,董宁霞.辛伐他汀治疗不稳定性心绞痛40例[J].陕西医学杂志,2004,33(8):742-743. 被引量:2
  • 2白书玲,李建军.C反应蛋白与动脉粥样硬化[J].中华心血管病杂志,2004,32(8):765-768. 被引量:133
  • 3Steven E. Nissen,Stephen J. Nicholls,Ilks Sipahi,Peter Libby,Joel S. Raichlen,Christie M. Ballantyne,Jean Davignon,Raimund Erbel,Jean Charles Fruchart,Jean-Claude Tardif,Paul Schoenhagen,Tim Crowe,Valerie Cain,Kathy Wolski,Marlene Coormastic,E. Murat Tuzcu,仝其广(译),王淑敏(译),胡大一(校).极高强度他汀治疗对冠状动脉粥样硬化消退的影响——ASTEROID试验[J].美国医学会杂志(中文版),2006,25(4):215-223. 被引量:347
  • 4Zwaka TP,Hombach V,Torzewski J.C-reactive protein-mediated low density lipoprotein uptake by macrophages:implications for atherosclerosis.Circulation,2001,103(9):1191.
  • 5Pepys MB,Hirschfield GM.C-reactive protein:A critical update[J].J Clin Invest,2003,111:1805-1812.
  • 6Thompson SG,Kienast J,Pyke SDM,et al.Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris[J].N Engl J Med,1995,332:635-641.
  • 7Calabro P,Willerson JT,Yeh ET.Inflammatory cytokines stimulated C-reactive protein production by human coronary artery smooth muscle cells[J].Circulation,2003,108:1930-1932.
  • 8Calabro P,Chang D,Willerson JT,et al.Release of C-reactive protein in re-sponse to inflammatory cytokines by human adipocytes[J].J Am Coll Cardiol,2005,46:1112-1113.
  • 9Schwedler SB,Amann K,Wernicke K,et al.Native C-reactive protein increases whereas modified C-reactive protein reduces atherosclerosis in apolipoprotein E-knockout mice[J].Circulation,2005,112:1016-1023.
  • 10Ridker PM,Rifai N,Clearfield M,et al.Air Force/Texas Coronary Atherosclerosis Prevention Study Investigators.Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events[J].N Engl J Med,2001,344(26):1959-1965.

共引文献2899

同被引文献9

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部